"Nulla porta a un risultato subito. Noi ci sentiamo ingaggiati in una lotta complessa, perché il cancro è una malattia complessa, sia dal punto di vista biologico che sociale". Luca Boldrini, Medico e ricercatore Fondazione AIRC per la ricerca sul cancro presso il Policlinico Gemelli #IGiorniDellaRicerca

(12/n) It is a stark reminder that even fundamentally paradigm shifting advances in technology may not overcome the technology chasm. I hope that is not true and humanity ultimately wins. In the meantime, see you again ViewRay #MRIdian.

Celebrating the incredible work of the youngAIRO Steering Committee at #AIRO2023! 🙌 Their dedication and passion for advancing #radonc and motivating the new generation is truly inspiring. Hats off to this dynamic team! Viola Salvestrini GiuseppeC. Iorio MD roberta grassi Fra

2023-24 board members of Italian young AIRO youngAIRO 🇮🇹 Team effort💪🏻 #AIRO2023 GiuseppeC. Iorio MD roberta grassi

Without a quick and comprehensive resolution, the #MRIdian platform will disappear. Patients will miss out, and technical innovation in radiotherapy will be derailed. But we will not go quietly into that good night… read our open letter to the #radonc community👍

Consequence to me: 👉 WE need to initiate and tell the stories about the benefits of modern Radiation Oncology as an important pillar of interdisciplinary cancer care 👉 we CANNOT expect others doing so 👉 we = all #radonc ESTRO ASTRO ISRSy the Radiosurgery Society …

The 10th MRinRT Symposium will take place at Fondazione Policlinico Universitario Agostino Gemelli IRCCS, in Rome, on 3-5 April 2024! mrinrt2024.com ⚡️Outstanding faculty and scientific programme 🧨 EB Registration 29 Feb 💣 Regular Registration 02 Apr

🌟Spotlight on online Adaptive RadioTherapy (ART) at the #ESTRO24 #RTT pre-meeting course. This course will provide the essential skills for safely practicing online #ART. 🔎 Explore the Scientific Programme: bit.ly/3S0J3aq ⏳#ESTRO24 Early registration fee until 24 Jan.

🗳️Election time coming up! We’re delighted to unveil the 2 candidates for ESTRO President: Barbara Jereczek-Fossa and Dirk Verellen. 📅 Voting opens on 19 February. ESTRO members will receive an email with some details tomorrow. Watch your mailbox!

Discussing and practice changing studies in #radonc with AIRO and @airo_giovani and friends…a few steps from the Colosseum! 💥 #radiotherapy #Science #cancer #ESTRO #ASTRO

Today one of the peaks of my #radonc career, as one of my #rolemodels showed my akward face in one of his lecture. Thanks Luca Boldrini it’s an honour. (Yes I need a professional headshot 😂😂😂) #radonc #inspiration

Aggregate safety data for pembrolizumab monotherapy across trials in European Journal of Cancer with Dr. Dr. Julie Brahmer et al (n=8937). G3+ AEs in 51% of pts, discontinuation from AE in 13%, fatal AEs 6%. Median time to immune-mediated AE was 85d. ejcancer.com/article/S0959-…

Elsevier is pleased to share from January's issue "Rectal Cancer MRI Guided Radiotherapy: A Practical Review for the Physician" by Dr. Giuditta Chiloiro, Dr. Gani Cihan Gani, and Dr. Boldrini Luca Boldrini sciencedirect.com/science/articl…

#NRG2024 meeting in Bologna 🇮🇹 Such a great event and what a wonderful #RadOncTeam ✌️✌️✌️ #AIROyoung NutriOnc Research Group

Sesión plenaria del #CONGRESOSEOR24 con SEOR.es ESTRO ALATRO #FARO Mamen Rubio Luca Boldrini #SPRO